Summit X LLC’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-5,352
Closed -$817K 136
2025
Q2
$817K Buy
5,352
+190
+4% +$29.2K 0.15% 108
2025
Q1
$856K Buy
5,162
+9
+0.2% +$1.41K 0.18% 100
2024
Q4
$745K Buy
5,153
+87
+2% +$13.5K 0.17% 98
2024
Q3
$740K Sell
5,066
-126
-2% -$20.1K 0.18% 94
2024
Q2
$759K Buy
5,192
+121
+2% +$18K 0.17% 97
2024
Q1
$803K Buy
5,071
+2,602
+105% +$414K 0.21% 94
2023
Q4
$387K Sell
2,469
-83
-3% -$12.7K 0.11% 126
2023
Q3
$398K Sell
2,552
-1,224
-32% -$202K 0.13% 119
2023
Q2
$626K Buy
3,776
+75
+2% +$12.1K 0.15% 134
2023
Q1
$574K Buy
3,701
+471
+15% +$76.1K 0.15% 138
2022
Q4
$574K Sell
3,230
-256
-7% -$44.2K 0.17% 134
2022
Q3
$567K Buy
3,486
+252
+8% +$42.6K 0.17% 137
2022
Q2
$576K Sell
3,234
-23
-0.7% -$4.1K 0.17% 133
2022
Q1
$579K Buy
3,257
+164
+5% +$27.9K 0.14% 145
2021
Q4
$528K Buy
3,093
+122
+4% +$20K 0.12% 164
2021
Q3
$477K Sell
2,971
-4,707
-61% -$803K 0.12% 173
2021
Q2
$1.27M Sell
7,678
-157
-2% -$26K 0.32% 72
2021
Q1
$1.29M Buy
7,835
+644
+9% +$104K 0.35% 68
2020
Q4
$1.13M Sell
7,191
-478
-6% -$70.5K 0.33% 70
2020
Q3
$12.2K Sell
7,669
-69
-0.9% -$10.2K 0.2% 73
2020
Q2
$1.08M Buy
7,738
+152
+2% +$22.2K 0.4% 66
2020
Q1
$996K Buy
7,586
+4
+0.1% +$567 0.46% 59
2019
Q4
$1.11M Buy
7,582
+257
+4% +$34.9K 0.41% 61
2019
Q3
$980K Buy
7,325
+526
+8% +$69.3K 0.39% 67
2019
Q2
$944K Sell
6,799
-224
-3% -$31K 0.39% 65
2019
Q1
$978K Buy
7,023
+289
+4% +$38.7K 0.42% 63
2018
Q4
$868K Buy
6,734
+586
+10% +$81.7K 0.5% 49
2018
Q3
$852K Buy
6,148
+152
+3% +$20.2K 0.42% 56
2018
Q2
$721K Buy
5,996
+246
+4% +$30.7K 0.4% 58
2018
Q1
$735K Buy
5,750
+137
+2% +$18.5K 0.44% 52
2017
Q4
$787K Buy
5,613
+350
+7% +$48.8K 0.5% 46
2017
Q3
$687K Sell
5,263
-47
-0.9% -$6.23K 0.46% 54
2017
Q2
$702K Buy
+5,310
New +$677K 0.5% 54

Other funds holding JNJ

Summit X LLC's JNJ Position: Q3 2025 in Review

Summit X LLC sold out of Johnson & Johnson (JNJ) in Q3 2025, closing a stake of 5,352 shares — an estimated $817K sold.

Summit X LLC first reported a position in JNJ in Q2 2017 and held it in 33 quarters. The position peaked at $1.29M in Q1 2021. 4,187 funds tracked by Wall St. Rank hold JNJ as of Q3 2025.

  • Summit X LLC reported no remaining Johnson & Johnson position as of Q3 2025 after selling out during the quarter.
  • Summit X LLC sold 5,352 Johnson & Johnson shares in Q3 2025, an estimated $817K.
  • Summit X LLC first reported a position in Johnson & Johnson in Q2 2017 and held it in 33 quarters.
  • Summit X LLC's Johnson & Johnson position peaked at $1.29M in Q1 2021.
  • 4,187 funds tracked by Wall St. Rank held Johnson & Johnson as of Q3 2025.

Based on Summit X LLC's 13F filing for Q3 2025.